DSIP (5 mg vial)

Protocol Overview

Concise summary of the regimen.

Dosing & Reconstitution

Frequency: Inject once daily subcutaneously, typically in the evening before bedtime. For 10 unit (0.10 mL) or smaller administrations (Weeks 1 to 2), consider 30- or 50-unit insulin syringes for improved readability.

Reconstitution Steps

1. Draw 3.0 mL bacteriostatic water with a sterile syringe.
2. Inject slowly down the vial wall; avoid foaming.
3. Gently swirl until dissolved (do not shake).
4. Label and refrigerate at 2 to 8 °C, protected from light. At 1.67 mg/mL, 1 unit = 0.01 mL » 16.7 mcg on a U-100 insulin syringe.

Storage Instructions

Proper storage preserves peptide quality.

• Lyophilized: store at -20 °C in dry, dark conditions; minimize moisture exposure.
• Reconstituted: refrigerate at 2 to 8 °C; use within ~4 weeks; avoid freeze-thaw.
• Allow vials to reach room temperature before opening to reduce condensation uptake.

Supplies Needed

Plan based on an 8 to 12 week daily protocol with gradual titration.

Peptide Vials (DSIP, 5 mg each):

• 8 weeks at ~200 mcg/day avg: 2 to 3 vials.
• 12 weeks at ~200 mcg/day avg: 3 to 4 vials.
• 12 weeks at ~300 mcg/day avg: 5 to 6 vials.

Insulin Syringes (U-100):

• Per week: 7 syringes (1/day).
• 8 weeks: 56. 12 weeks: 84.

Bacteriostatic Water (10 mL bottles):

• 3 vials: 1 bottle. 5 vials: 2 bottles. 6 vials: 2 bottles.

Alcohol Swabs:

• Per week: 14 swabs.
• 8 weeks: 112 (2 x 100-count). 12 weeks: 168 (2 x 100-count).

Important Notes

Practical considerations for consistency and safety.

• Use new sterile insulin syringes; dispose in a sharps container.
• Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation.
• Inject slowly; wait a few seconds before withdrawing the needle.
• Document daily dose and site rotation to maintain consistency.
• Some research suggests DSIP effects may persist for multiple nights after dosing; adjust frequency as

needed.

How This Works

DSIP (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) was first characterized in 1977 as a sleep-modulating factor isolated from rabbit brain. Mechanistic studies suggest DSIP may influence sleep by modulating GABAergic transmission and interacting with opioid receptor systems. Research indicates it can increase delta-wave (slow-wave) sleep duration without significantly altering REM sleep architecture. Beyond sleep, DSIP has demonstrated stress-protective and adaptogenic properties in various models, potentially through modulation of the hypothalamic-pituitary-adrenal axis.

Benefits & Side Effects

Observations from preclinical and clinical literature.

• May promote deeper, more restorative slow-wave sleep and improve subjective sleep quality.
• Research suggests potential stress-protective and anxiolytic-like effects.
• Some studies indicate DSIP does not induce pharmacological tolerance with continued use.
• Generally well tolerated in human studies; occasional mild injection-site reactions may occur.
• Limited long-term safety data; periodic breaks are recommended as a precaution.

Lifestyle Factors

Complementary strategies for best outcomes.

• Maintain consistent sleep-wake schedules to reinforce circadian rhythms.
• Limit blue light exposure and stimulants (caffeine, nicotine) in the hours before bed.
• Create a cool, dark, quiet sleep environment.
• Incorporate regular physical activity, ideally earlier in the day.
• Manage stress through relaxation techniques (meditation, deep breathing).

Injection Technique

General subcutaneous guidance from clinical best-practice resources.

1. Clean the vial stopper and skin with alcohol; allow to dry.
2. Pinch a skinfold; insert the needle at 45 to 90 degrees into subcutaneous tissue.
3. Do not aspirate for subcutaneous injections; inject slowly and steadily.
4. Wait 5 to 10 seconds before withdrawing; dispose of syringe in sharps container.
5. Rotate sites systematically (abdomen, thighs, upper arms) to avoid lipohypertrophy.

References

Source citations for further reading.

1. Schoenenberger GA, Monnier M. Characterization of a delta-electroencephalogram (sleep)-inducing peptide (Proc Natl Acad Sci USA, 1977).
2. Schneider-Helmert D, Schoenenberger GA. Effects of DSIP in man: multifunctional psychophysiological properties (Neuropsychobiology, 1983).
3. Sudakov KV et al. Delta-sleep-inducing peptide: stress protective effect (Ann N Y Acad Sci, 2004).
4. Graf MV, Kastin AJ. Delta-sleep-inducing peptide (DSIP): a review (Neurosci Biobehav Rev, 1984).